The myeloperoxidase activity (OD at 450 nm) of the experimental
groups varied significantly (p < 0.05) in the treatment
groups and showed decreasing trend from 14 to 28 days followed
by an increasing trend from 28 days to 42 days of sampling. The
highest myeloperoxidase activity was found to be in treatment
group T3 followed by T2 and T5